The president says he is still negotiating with Sen. Kyrsten Sinema, who is opposed to raising taxes to pay for the Democrats' social spending bill.
Those following along with Clover Health Investments, Corp. ( NASDAQ:CLOV ) will no doubt be intrigued by the recent...
Don't forget about Novavax (NASDAQ: NVAX). Here's why Novavax stock could skyrocket in December. In this case, there could be increased demand for vaccines that are effective against the omicron variant.
Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.
On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions.
The professor is known for being bullish on stocks, yet even he says trouble’s coming.
Satya Nadella sold 838,584 shares between Nov. 23 and Nov. 24. The move comes a month before Washington state's capital gains tax goes into effect.
Stock prices can go up and down for a number of reasons in the near term, but over many years, stocks tend to follow the underlying growth of the company. While Alibaba (NYSE: BABA) and Stitch Fix (NASDAQ: SFIX) have seen their share prices crater this year, both companies continue to post solid operating results. Here's why these growth stocks could be bargains at current prices.
Creating reliable streams of retirement income is one of the most important elements of a person’s financial plan. A retirement industry giant says it now has a new way for retirees to meet this vital challenge. Fidelity Investments plans to … Continue reading → The post There’s a New Way to Convert Your 401(k) into a Pension-like Stream of Income appeared first on SmartAsset Blog.
Scotiabank reported net income of $9,955 million for the fiscal year 2021, compared with net income of $6,853 million in 2020. Diluted earnings per share (EPS) were $7.70, compared to $5.30 in the previous year. Return on equity was 14.7%, compared to 10.4% in the previous year.
After sliding along with the rest of the stock market on Friday, shares of lithium mining stock Lithium Americas (NYSE: LAC) are rebounding in a big way on Monday -- up 13.6% as of 12:15 p.m. ET. You can thank the friendly analysts at National Bank Financial for that. No sooner had Lithium Americas finished its Friday slide than an analyst at the Canadian investment bank stepped in and reiterated an outperform recommendation on the stock.
U.S. legalization is still stalled, but Mexican marijuana legalization could be imminent.
Sundial Growers (NASDAQ: SNDL) has come a long way since its explosion onto the public scene and its brief tenure as a meme stock. Formerly a small regional marijuana company in Canada, Sundial has effectively leveraged its popularity to become something more than a cannabis seller, and it now has a shot at becoming a serious player in the industry. Rather than prioritizing growing and selling marijuana, Sundial is positioning itself to be a kingmaker and principal investor for smaller cannabis companies in Canada.
Moderna CEO Stephane Bancel predicts a 'material drop' in the effectiveness of current vaccines against the Omicron variant.
After hitting an all-time high of nearly $300 per share earlier this year, shares of CrowdStrike (NASDAQ: CRWD) have slid sharply recently. Trading at about $225 headed into the company's earnings report later this week, the stock is approximately down 25% from its all-time high. Can tech company's upcoming earnings report help revitalize interest in the stock?
Words have power -- as investors discovered to their dismay last week. News of the new omicron variant of COVID-19 shocked the stock market, sending shares of cruise line stocks Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL) (NYSE: CUK), and Norwegian Cruise Line Holdings (NYSE: NCLH) tumbling 10% and more in Friday trading.
Growth in its core Chinese e-commerce division, as well as in cloud computing and its international business, are likely to be crucial to Alibaba's stock.
A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
Shortly after Sundar Pichai became CEO of Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) in 2015, he boldly proclaimed that his vision was to evolve into an AI-first company. Alphabet's consistent investments to support long-term growth are certainly reflected in its strong financial performance. Although the company competes with other technology behemoths such as Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Netflix (NASDAQ: NFLX), Alphabet's most recent quarterly results lead me to believe that it could very well become the biggest company in the world in terms of market cap in the not-too-distant future, replacing Apple (NASDAQ: AAPL).
Dow Jones futures dived 400 points early Tuesday, as the Moderna CEO predicted existing vaccines will be less effective for omicron.
Adagio Therapeutics Inc. is riding high after the company said its experimental antibody is likely to be just as effective against the omicron variant of the coronavirus as it is against previous variants. The antibody, a drug called ADG20, affords protection for up to one year, according to the firm.